missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD3 Mouse anti-Human, Clone: B-B11, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NBP3-14571-500UL
663.00 EUR valid until 2025-12-16
BEST PRICE on Promo! Use promo code "24090" to get your promotional price.
This item is not returnable.
View return policy
Description
CD3 Monoclonal antibody specifically detects CD3 in Human samples. It is validated for Flow Cytometry, Functional Assay
Specifications
| CD3 | |
| Monoclonal | |
| 1 mg/mL | |
| Flow Cytometry, Functional | |
| CD_antigen: CD3e, CD3 antigen, delta subunit, CD3d antigen, CD3d antigen, delta polypeptide (TiT3 complex), CD3d molecule, delta (CD3-TCR complex), CD3-DELTA, CD3e, CD3e antigen, CD3e antigen, epsilon polypeptide (TiT3 complex), CD3e molecule, epsilon (CD3-TCR complex), CD3-epsilon, CD3G, CD3g antigen, CD3g antigen, gamma polypeptide (TiT3 complex), CD3g molecule, epsilon (CD3-TCR complex), CD3g molecule, gamma (CD3-TCR complex), CD3-GAMMA, FLJ17620, FLJ17664, FLJ18683, FLJ79544, FLJ94613, IMD18, MGC138597, T3DOKT3, delta chain, T3E, T-cell antigen receptor complex, epsilon subunit of T3, T-cell receptor T3 delta chain, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 delta chain, T-cell surface glycoprotein CD3 epsilon chain, TCRE | |
| PHA activated T cells | |
| 500 μg | |
| Adaptive Immunity, Apoptosis, Autoimmune Diseases, Diabetes Research, Immunology, Inflammation, Innate Immunity, Signal Transduction, Stem Cells | |
| 916 | |
| Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. | |
| Purified |
| Flow Cytometry, Functional Assay | |
| B-B11 | |
| Unconjugated | |
| PBS. Sterile-filtered through 0.22 um. | |
| Mouse | |
| Affinity purified | |
| RUO | |
| Primary | |
| Human | |
| Antibody | |
| IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction